Daewha Sees Promise In Herbal-Derived Alzheimer’s Candidate
This article was originally published in PharmAsia News
Executive Summary
In a rare move, South Korea's Daehwa Pharm is progressing the development of a herbal-derived therapy for Alzheimer's disease, a sector where many pharma firms have been conducting R&D but have faced challenges and failures.